Literature DB >> 21613463

Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus.

M M Lafer1, L Y Weckx, M I de Moraes-Pinto, A Garretson, S P Steinberg, A A Gershon, P S LaRussa.   

Abstract

A flow cytometry-adapted fluorescent antibody to membrane antigen (FAMA) assay to detect IgG antibodies against varicella-zoster virus (VZV) was developed and tested in 62 serum samples, showing 90.32% accuracy obtained from a receiver operating characteristic (ROC) curve with a 0.9125 (95% confidence interval [CI], 0.829 to 1.00) area below the curve compared to the result with standard FAMA.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21613463      PMCID： PMC3147325          DOI： 10.1128/CVI.05130-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  14 in total

1.  A simple and cheaper in house varicella zoster virus antibody indirect ELISA.

Authors:  Erika Ono; Manuel Mindlin Lafer; Lily Yin Weckx; Celso Granato; Maria Isabel de Moraes-Pinto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2004-07-20       Impact factor: 1.846

2.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

Review 3.  Preventing varicella-zoster disease.

Authors:  Sophie Hambleton; Anne A Gershon
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.

Authors:  L Saiman; P LaRussa; S P Steinberg; J Zhou; K Baron; S Whittier; P Della-Latta; A A Gershon
Journal:  Infect Control Hosp Epidemiol       Date:  2001-05       Impact factor: 3.254

5.  Detection of antibodies to varicella-zoster virus using a latex agglutination assay.

Authors:  A A Gershon; P Larussa; S Steinberg
Journal:  Clin Diagn Virol       Date:  1994-08

6.  Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

Authors:  David E Michalik; Sharon P Steinberg; Philip S Larussa; Kathryn M Edwards; Peter F Wright; Ann M Arvin; Haley A Gans; Anne A Gershon
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

7.  Ten year follow-up of healthy children who received one or two injections of varicella vaccine.

Authors:  Barbara Kuter; Holly Matthews; Henry Shinefield; Steve Black; Penelope Dennehy; Barbara Watson; Keith Reisinger; Lee Lian Kim; Lisa Lupinacci; Jonathan Hartzel; Ivan Chan
Journal:  Pediatr Infect Dis J       Date:  2004-02       Impact factor: 2.129

8.  Comparison of latex agglutination test with enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus.

Authors:  M L Landry; D Ferguson
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

9.  Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay.

Authors:  P A C Maple; J Gray; J Breuer; G Kafatos; S Parker; D Brown
Journal:  Clin Vaccine Immunol       Date:  2006-02

10.  Laboratory studies of acute varicella and varicella immune status.

Authors:  H H Balfour; C K Edelman; C L Dirksen; D R Palermo; C S Suarez; J Kelly; J T Kentala; D D Crane
Journal:  Diagn Microbiol Infect Dis       Date:  1988-07       Impact factor: 2.803
View more
  5 in total

1.  Immunological characteristics of MAV/06 strain of varicella-zoster virus vaccine in an animal model.

Authors:  Duckhyang Shin; Younchul Shin; Eunmi Kim; Hyojung Nam; Haiyan Nan; Jaewoo Lee
Journal:  BMC Immunol       Date:  2022-06-03       Impact factor: 3.594

Review 2.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

3.  Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay.

Authors:  Jeffrey I Cohen; Mir A Ali; Ahmad Bayat; Sharon P Steinberg; Hosun Park; Anne A Gershon; Peter D Burbelo
Journal:  Clin Vaccine Immunol       Date:  2014-07-02

4.  Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay.

Authors:  Jian Liu; Xiangzhong Ye; Jizong Jia; Rui Zhu; Lina Wang; Chunye Chen; Lianwei Yang; Yongmei Wang; Wei Wang; Jianghui Ye; Yimin Li; Hua Zhu; Qinjian Zhao; Tong Cheng; Ningshao Xia
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

5.  The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.

Authors:  P A C Maple; J Haedicke; M Quinlivan; S P Steinberg; A A Gershon; K E Brown; J Breuer
Journal:  Epidemiol Infect       Date:  2016-03-28       Impact factor: 2.451
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.